Is Indo Us Biotech the Best Stock in Its Sector? A Look at the Numbers
- September 29, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Indo Us Biotech CMP Rs 77 (29 Sep 2026). Market cap Rs 156 Cr. ROE 14.18%. P/E 13.59x versus Industry P/E 37.36x.
Quick Answer
Indo Us Biotech is one of the names investors compare when screening the Agri sector, built on a 14.18% return on equity and a P/E of 13.59x against an Industry P/E of 37.36x. Whether Indo Us Biotech is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Agri sector peers, so you can judge that for yourself.
Is Indo Us Biotech the best stock in its sector? The stock trades on the NSE at Rs 77 as of 29 September 2026, within its 52-week range of Rs 70.00 to Rs 159.00. Indo US Bio-Tech Ltd breeds, produces and markets vegetable, cotton and oilseed varieties and offers seed, soil and water testing services.
Indo Us Biotech sits in the Agri sector, and its 14.18% ROE and 13.59x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Indo Us Biotech
Indo US Bio-Tech Ltd breeds, produces and markets vegetable, cotton and oilseed varieties and offers seed, soil and water testing services. The stock is trading close to its 52-week low after falling by about half from its high, and it is a micro-cap with very thin volumes. At a market capitalisation of Rs 156 Cr, it is tracked as part of the Agri sector on Univest.
Is Indo Us Biotech the Best Stock in Its Sector?
Indo Us Biotech makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 14.18% ROE with a 13.59x P/E against the sector’s 37.36x Industry P/E. Indo Us Biotech’s 13.59x P/E is well below the 37.36x Industry P/E with a 14.18% ROE, but it is a thinly traded micro-cap and the stock has fallen by about half from its 52-week high.
| Metric | Indo Us Biotech |
|---|---|
| CMP (NSE) | Rs 77.45 |
| 52-Week High / Low | Rs 159.00 / Rs 70.00 |
| Market Cap | Rs 156 Cr |
| P/E (TTM) vs Industry P/E | 13.59x vs 37.36x |
| P/B | 1.68 |
| ROE | 14.18% |
| EPS (TTM) | Rs 5.71 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.40 |
Compare Indo Us Biotech Against Other Agri Sector Stocks
How Indo Us Biotech Compares Against Its Agri Sector Peers
The table below sets Indo Us Biotech against 2 other Agri sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Indo Us Biotech | 156 | 13.59 | 14.18% | 0.40 |
| India Pesticides | 1,541 | 14.32 | 11.86% | 0.11 |
| Insecticides India | 1,770 | 14.14 | 11.42% | 0.13 |
| Peer average (2 companies) | – | 14.23 | 11.64% | 0.12 |
Against this peer set, Indo Us Biotech’s 14.18% ROE is above the 11.64% peer average, and its P/E of 13.59x runs below the peer average of 14.23x. Indo Us Biotech’s 13.59x P/E is well below the 37.36x Industry P/E with a 14.18% ROE, but it is a thinly traded micro-cap and the stock has fallen by about half from its 52-week high.
What Makes Indo Us Biotech Worth Watching in Agri
- Well below Industry P/E: A 13.59x P/E against a 37.36x Industry P/E is a wide discount for a business with a 14.18% ROE.
- Solid ROE: A 14.18% ROE is a healthy figure for a seed company.
- Micro-cap scale: At a market capitalisation of Rs 156 Cr the company is small, so results and prices can move sharply.
Indo Us Biotech Valuation: Is It Justified?
Indo Us Biotech’s 13.59x P/E is well below the 37.36x Industry P/E with a 14.18% ROE, but it is a thinly traded micro-cap and the stock has fallen by about half from its 52-week high. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Indegene the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Indo Us Biotech and other Agri sector stocks.
How to Track Indo Us Biotech Before You Invest
Before deciding whether Indo Us Biotech deserves its label as the best stock in its sector for your own portfolio, compare it directly against Agri sector peers using the steps below.
- Open the Univest Screener and search for Indo Us Biotech to view live price, valuation ratios, and peer comparisons within the Agri sector.
- Compare its P/E, P/B, and ROE against other Agri sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Indo Us Biotech earns a place in the best stock in its sector conversation on the strength of a 14.18% ROE and a P/E of 13.59x against a 37.36x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Indo Us Biotech the best stock in its sector?
Ans. Indo Us Biotech has a 14.18% ROE and trades at 13.59x P/E against a 37.36x Industry P/E, and compares above the peer average ROE of 11.64% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Indo Us Biotech?
Ans. Indo Us Biotech was trading at Rs 77.45 on the NSE as of 29 September 2026, within its 52-week range of Rs 70.00 to Rs 159.00.
What sector does Indo Us Biotech belong to?
Ans. Indo Us Biotech is classified under the Agri sector on Univest.
How does Indo Us Biotech compare to its sector peers on P/E?
Ans. Indo Us Biotech’s P/E of 13.59x is below the 14.23x average of the 2 named peers compared in this article.
What is Indo Us Biotech’s return on equity?
Ans. Indo Us Biotech reported a return on equity of 14.18%, which is above the 11.64% average of its named peers in this comparison.
Should I invest in Indo Us Biotech based on its sector position?
Ans. Indo Us Biotech’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
